[ad_1]
Phillips posted adjusted earnings before interest, taxes and depreciation for the second quarter, which met badysts' expectations. In addition, the company has reiterated its targets for 2017-2020 and continues to make progress in the production of defibrillators in the United States.
Philips van Huten, CEO of Philips, said that because of the nature of its supply chain, the company to absorb the costs, but this is not always possible and will affect patients and hospitals at some point.
Look at the entire commentary in the video.
[ad_2]
Source link
